TY  - JOUR

T1  - Neoadjuvant capecitabine and oxaliplatin (CAPOX) followed by chemoradiation (CRT) in high-risk rectal cancer: A single-institution experience.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2012.30.15_suppl.e14100

PY  - 2012/05/20

AU  - Ahmad S

AU  - Parashar D

AU  - Jephcott CR

AU  - Ford H

AU  - Wilson C

ED  - 

DO  - DOI: 10.1200/jco.2012.30.15_suppl.e14100

PB  - American Society of Clinical Oncology (ASCO)

VL  - 30

IS  - 15_suppl

SP  - e14100

EP  - e14100

Y2  - 2026/10/28

ER  -